Muhammad Naufal Bin Omar's journey took him from Malaysia to Korea as an exchange student and finally to the cosmetics brand Glutanex as social media manager, a winding road that blended fortuitous timing with perseverance and confidence.
Korea’s top pharmaceutical lobby is under fire for allegedly strong-arming the removal of health supplements from Daiso shelves, with the country’s antitrust watchdog eyeing sanctions.
Celltrion, a major Korean biopharmaceutical firm, estimated that its second-quarter operating profit more than tripled from a year earlier on robust sales of high-margin biosimilar products.
The Korean unit of Danish health care giant Novo Nordisk signed a memorandum of understanding with Seoul National University Bundang Hospital to cooperate on chronic disorder trials and research.
An investor relations event hosted by the province of Gangwon was held at its community hall located in Mapo District, western Seoul on Tuesday. Around 100 people including Gangwon Governor Kim Jin-tae attended the event.
JW1601, an oral atopy treatment candidate that was licensed by JW Pharmaceutical to Ballerup, Denmark-based Leo Pharma began Phase 2 clinical trials, the Korean company said Wednesday.
GC Pharma won a $48.9 million flu vaccine deal with the Pan American Health Organization (PAHO), the company said Monday.
Korean biopharmaceutical companies are enjoying a strong third quarter on the lingering Covid-19 pandemic and sales of vaccines they produce under contract manufacturing organization (CMO) deals.
GNT Pharma's stroke treatment candidate Nelonemdaz won approval to start Phase 3 clinical trials in Korea, the company said Tuesday.
GC Pharma signed a partnership agreement with Austin, Texas-based Speragen for joint development of a treatment for succinic semialdehyde dehydrogenase deficiency (Ssadhd), the company said Tuesday.
Korea JoongAng Daily Sitemap
